APA Alıntı

De Pauw, I., Lardon, F., Van den Bossche, J., Baysal, H., Fransen, E., Deschoolmeester, V., . . . Wouters, A. (2018). Simultaneous targeting of EGFR, HER2, and HER4 by afatinib overcomes intrinsic and acquired cetuximab resistance in head and neck squamous cell carcinoma cell lines. Mol Oncol.

Chicago Stili Alıntı

De Pauw, Ines, et al. "Simultaneous Targeting of EGFR, HER2, and HER4 By Afatinib Overcomes Intrinsic and Acquired Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma Cell Lines." Mol Oncol 2018.

MLA Alıntı

De Pauw, Ines, et al. "Simultaneous Targeting of EGFR, HER2, and HER4 By Afatinib Overcomes Intrinsic and Acquired Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma Cell Lines." Mol Oncol 2018.